首页> 美国卫生研究院文献>Journal of Orthopaedic Case Reports >A Randomized Open-Label Clinical Study Comparing the Efficacy Safety and Bioavailability of Calcium Lysinate with Calcium Carbonate and Calcium Citrate Malate in Osteopenia Patients
【2h】

A Randomized Open-Label Clinical Study Comparing the Efficacy Safety and Bioavailability of Calcium Lysinate with Calcium Carbonate and Calcium Citrate Malate in Osteopenia Patients

机译:骨质疏松症患者中赖氨酸钙碳酸钙和苹果酸苹果酸钙的疗效安全性和生物利用度的随机对照临床研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction:Many factors influence bone health, but osteoporosis is viewed as a calcium deficiency disorder in which bone is resorbed to maintain the serum calcium levels. Dietary calcium supplements have been recommended for the prevention of osteoporosis in the elderly. Many forms of dietary calcium supplements are widely available in market, but products containing calcium citrate and calcium carbonate are the most common. Calcium lysinate, a new form of calcium preparation, may have a better absorption and can be a better calcium supplement.
机译:简介:许多因素都会影响骨骼健康,但骨质疏松症被视为一种钙缺乏症,可吸收骨骼以维持血清钙水平。膳食钙补充剂已被推荐用于预防老年人的骨质疏松症。市场上有许多形式的膳食钙补充剂,但最常见的是含有柠檬酸钙和碳酸钙的产品。新型形式的钙制剂赖氨酸钙可能具有更好的吸收作用,并且可以成为更好的钙补充剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号